SVB Securities Keeps Their Buy Rating on PureTech Health (PRTC)
SVB Securities Remains a Buy on PureTech Health (PRTC)
Piper Sandler Maintains Overweight on PureTech Health, Raises Price Target to $44
Piper Sandler Adjusts Price Target on PureTech Health to $44 From $37, Reiterates Overweight Rating
SVB Securities Adjusts PureTech Health's Price Target to $70 from $66, Keeps Outperform Rating
SVB Securities Sticks to Their Buy Rating for PureTech Health (PRTC)
PureTech Health analyst ratings
SVB Leerink Maintains Outperform on PureTech Health, Raises Price Target to $70
Piper Sandler Adjusts PureTech Health's Price Target to $37 From $72, Reiterates Overweight Rating
PureTech Health analyst ratings
SVB Leerink Maintains Outperform on PureTech Health, Lowers Price Target to $66
No Data